Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
		
    WNT receptor signalling in lung physiology and pathology.
        
        Pharmacol. Ther. 187, 150-166 (2018)
    
    
    
				The WNT signalling cascades have emerged as critical regulators of a wide variety of biological aspects involved in lung development as well as in physiological and pathophysiological processes in the adult lung. WNTs (secreted glycoproteins) interact with various transmembrane receptors and co-receptors to activate signalling pathways that regulate transcriptional as well as non-transcriptional responses within cells. In physiological conditions, the majority of WNT receptors and co-receptors can be detected in the adult lung. However, dysregulation of WNT signalling pathways contributes to the development and progression of chronic lung pathologies, including idiopathic pulmonary fibrosis (IPF), chronic obstructive pulmonary disease (COPD), asthma and lung cancer. The interaction between a WNT and the (co-)receptor(s) present at the cell surface is the initial step in transducing an extracellular signal into an intracellular response. This proximal event in WNT signal transduction with (cell-specific) ligand-receptor interactions is of great interest as a potential target for pharmacological intervention. In this review we highlight the diverse expression of various WNT receptors and co-receptors in the aforementioned chronic lung diseases and discuss the currently available biologicals and pharmacological tools to modify proximal WNT signalling.
			
			
		Impact Factor
					Scopus SNIP
					
					Scopus
Cited By
					
					Cited By
Altmetric
					
				10.376
					2.753
					
					34
					
					
				Anmerkungen
				
					
						 
						
					
				
			
				
			
				Besondere Publikation
				
					
						 
					
				
			
			
			
				Auf Hompepage verbergern
				
					
						 
					
				
			
			
        Publikationstyp
        Artikel: Journalartikel
    
 
    
        Dokumenttyp
        Review
    
 
     
    
     
     
    
    
        Sprache
        englisch
    
 
    
        Veröffentlichungsjahr
        2018
    
 
     
    
        HGF-Berichtsjahr
        2018
    
 
    
    
        ISSN (print) / ISBN
        0163-7258
    
 
    
        e-ISSN
        1879-016X
    
 
     
     
     
	     
	 
	 
    
        Zeitschrift
        Pharmacology & Therapeutics.
    
 
		
    
        Quellenangaben
        
	    Band: 187,  
	    
	    Seiten: 150-166 
	    
	    
	
    
 
  
         
        
            Verlag
            Elsevier
        
 
         
	
         
         
         
         
         
	
         
         
         
    
         
         
         
         
         
         
         
    
        Begutachtungsstatus
        Peer reviewed
    
 
    
        Institut(e)
        Research Unit Lung Repair and Regeneration (LRR)
Institute of Lung Health and Immunity (LHI)
 
    Institute of Lung Health and Immunity (LHI)
        POF Topic(s)
        30202 - Environmental Health
    
 
    
        Forschungsfeld(er)
        Lung Research
    
 
    
        PSP-Element(e)
        G-503100-007
G-503100-001
G-503100-003
 
     
     	
    
    G-503100-001
G-503100-003
        Scopus ID
        85042587201
    
    
        PubMed ID
        29458107
    
    
        Erfassungsdatum
        2018-02-21